Relx PLC ADR (RELX)
RELX PLC ADR is a depositary receipt listed on the NYSE that represents common stock of RELX PLC. The underlying issuer is a London-based information and analytics group serving professional and business customers in North America, Europe, and other international markets. Its activities are organized across four segments: Risk, Scientific, Technical & Medical, Legal, and Exhibitions. The Risk business focuses on analytics and decision tools used in assessing and forecasting risk, and also includes commercial healthcare products. The Scientific, Technical & Medical segment provides data and information resources for science and healthcare. The Legal segment supplies legal, regulatory, and business information and analytics, while Exhibitions combines digital tools and data with in-person and online events. RELX PLC was incorporated in 1903 and was previously known as Reed Elsevier PLC before adopting its current name in July 2015.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-RELX
|
$41.38
|
25.3% Upside
|
Undervalued
|
$52.45
|
58.9% Upside
|
Bargain
|
Good
|
—
|
—
|
0.8986
|
3.7%
|
July 23, 2026
|
20.8x
|
18.2x
|
4.5x
|
59.012 B
|
67.576 B
|
14.1%
|
99.2%
|
3.5
|
57.2%
|
136.3%
|
